New research is focusing on the synergistic relationship between vitamin K2 and vitamin D3, for done and cardiovascular health. A group of naturally occurring and structurally similar fat-soluble vitamins, vitamin K is essential for the proper utilization of calcium. Through its activation of the protein osteocalcin, vitamin K helps to bind newly absorbed calcium to the mineral matrix in bone. In addition, vitamin K has been found to help maintain bone mineral density by decreasing the activity of osteoclasts, a cell that breaks down the bone matrix. Vitamin K also provides critical cardiovascular protection by helping to activate matrix Gla protein (MGP), an inhibitor of circulatory calcification. Thus, vitamin K and vitamin D not only share similar qualities, but they also act synergistically within the body.

The addition of MenaQ7®PRO to this formula is backed by extensive research. Dr. Leon Schurgers, world-renowned expert in vitamin K2 as MK-7 research for cardiovascular and bone health, and his team of research scientists have conducted over 15 clinical trials on MenaQ7®PRO through the University of Maastricht.

K2D3 includes 45mcg of MenaQ7®PRO, the most widely studied form of vitamin K2 and MK-7, and 5,000 IU of vitamin D3 per capsule for optimal absorption and use by the body.

Dosage: Take 1 or more capsule daily or as directed by your health care practitioner.

Also available in liquid, K2D3 Liquid, and in a stronger formula, K2D3 Max

Contraindications: Consult with your health care practitioner before beginning any Vitamin D therapy. Drug interaction is theoretically possible with drugs which are cleared via glucuronidation. Do not take K2 D3 if currently using anticoagulants.